Search Results - "Forti, Elisa"

  • Showing 1 - 12 results of 12
Refine Results
  1. 1
  2. 2

    Dysregulation of Iron Metabolism in Cholangiocarcinoma Stem-like Cells by Raggi, Chiara, Gammella, Elena, Correnti, Margherita, Buratti, Paolo, Forti, Elisa, Andersen, Jesper B, Alpini, Gianfranco, Glaser, Shannon, Alvaro, Domenico, Invernizzi, Pietro, Cairo, Gaetano, Recalcati, Stefania

    Published in Scientific reports (15-12-2017)
    “…Cholangiocarcinoma (CCA) is a devastating liver tumour arising from malignant transformation of bile duct epithelial cells. Cancer stem cells (CSC) are a…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

    Abstract 2677: Role of CLEC4D in inflammation-driven liver carcinogenesis by Riboldi, Elena, Tommaso, Luca Di, Clemente, Nausicaa, Raggi, Chiara, Forti, Elisa, Merlin, Simone, Pasqualini, Fabio, Follenzi, Antonia, Sica, Antonio

    Published in Cancer research (Chicago, Ill.) (01-07-2017)
    “…Abstract Hepatocellular carcinoma (HCC) accounts for approximately 90% of all primary liver tumors and is the second most deadly cancer in the world. HCC…”
    Get full text
    Journal Article
  9. 9

    COO, MYC / BCL2 Status and R-IPI Define a Group of Poor Prognosis DLBCL Patients in a Real-World Clinical Setting by Bettelli, Stefania, Marcheselli, Raffaella, Pozzi, Samantha, Marcheselli, Luigi, Papotti, Robel, Forti, Elisa, Cox, M. Christina Christina, Di Napoli, Arianna, Tadmor, Tamar, Maiorana, Antonino, Donati, Valentina, Galimberti, Sara, Sacchi, Stefano

    Published in Blood (13-11-2019)
    “…BACKGROUND In DLBCL, and mainly in advanced-stage, the presence of an activated B-cell phenotype or a non-GCB phenotype, and the coexpression of Myc and Bcl2…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12